Valutazione Della Politica di Pricing Dei Farmaci Oncologici Innovativi: Correlazione Tra Costi e Sopravvivenza in 15 Paesi Europei-Reference-Cited by-同舟云学术

Valutazione Della Politica di Pricing Dei Farmaci Oncologici Innovativi: Correlazione Tra Costi e Sopravvivenza in 15 Paesi Europei

Published:2016-04-11 Issue:1 Volume:4 Page:grhta.5000244
ISSN:2284-2403
Container-title:Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish
language:en
Short-container-title:Global & Regional Health Technology Assessment

Author:

Mengato Daniele¹²,Decannas Francesca³

Affiliation:

1. Scuola di Specializzazione in Farmacia Ospedaliera, Dipartimento di Scienze del Farmaco, Università degli Studi di Padova, Padova - Italy

2. Società Italiana di Farmacia Clinica e Terapia (SIFaCT), Milano - Italy

3. Scuola di Specializzazione in Farmacia Ospedaliera, Dipartimento di Chimica e Tecnologie del Farmaco, Università degli Studi di Roma “La Sapienza”, Roma - Italy

Publisher

Aboutscience Srl

Subject

Health Policy

Link

http://journals.sagepub.com/doi/pdf/10.5301/grhta.5000244

Reference9 articles.

1. Some considerations about the value based pricing in oncology: an analysis on metastatic first line medicinal products

2. The NICE Cost-Effectiveness Threshold

3. The Ends Justify the Mean: Outcome Measures for Estimating the Value of New Cancer Therapies

4. Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness

5. Pricing of innovative drugs: correlation between incremental cost and survival gain in four countries

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valore delle tecnologie sanitarie, HTA, decisioni;Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish;2017-01